Nabriva Therapeutics AG (NBRV) Receiving Somewhat Favorable News Coverage, Study Finds

For every buyer, there needs to be someone who sold them the shares they bought, just as there must be a buyer in order for a seller to get rid of his or her shares.

Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans.

A number of other analysts also recently issued reports on the company.

Nabriva Therapeutics plc (NBRV) surprised the stock market in its last reported earnings when it earned -$0.54 a piece versus the consensus-estimated -$0.6.

Nabriva Therapeutics plc (NBRV) saw -14.35 million in free cash flow last quarter, representing a quarterly net change in cash of -5.47 million.

Needham now has a $18.0 target on the $302.55 million market cap company or 117.92 % upside potential. The share price has moved backward from its 20 days moving average, trading at a distance of -3.29% and stays -12.7% away from its 50 days moving average. Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Nabriva Therapeutics AG in a research note on Friday, June 23rd. The rating was maintained by Wedbush on Wednesday, February 1 with "Outperform".

Analyst recommendations as reported on FINVIZ are rated on a 1 to 5 scale.

Investors wait Nabriva Therapeutics plc - Ordinary Shares (NASDAQ:NBRV) to report on November, 15. its quarterly earnings Wall Street analysts expect $-0.56 EPS, up $0.10 or 15.15 % from last year's $-0.66 same quarter earnings.

Several equities research analysts recently commented on NBRV shares. Almanack Investment Partners. has an ownership of 907,183 stocks of the biotechnology firms shares valued $1,633,000 following purchasing an extra 751,366 shares through out the previous quarter, Wellington Management Group LLP upped its stake in Nabriva Therapeutics AG by 9.9% through out the 1st period. ValuEngine raised shares of Nabriva Therapeutics AG from a "sell" rating to a "hold" rating in a research note on Saturday, June 24th. As of quarter end Hillhouse Capital Management, Ltd. had sold 500 shares trimming its position 0.1%. The corporation has a consensus rating of "Buy" and an consensus price target of $19.13. Research Firm Zacks boosted Nabriva Therapeutics AG from a "hold" recommendation to a "buy" recommendation and fixed a $12.00 PT for the company in a study note published on early Thur, Aug 10th.

Nabriva Therapeutics plc has a consensus outperform rating from 7 Wall Street analysts, and the number of shares now sold short amount to at least 0.41% of shares outstanding. The company now has an average rating of Buy and a consensus price target of $19.13. If you are reading this piece on another site, it was copied illegally and republished in violation of USA and worldwide copyright laws. The correct version of this piece of content can be accessed at The stock was sold at an average price of $8.56, for a total value of $313,364.48. Following the completion of the sale, the insider now directly owns 2,591,396 shares in the company, valued at approximately $28,401,700.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The rating was initiated by Needham with "Buy" on Monday, October 12. For the quarter, shares have been noted at -26.36%. The disclosure for this purchase can be found here.

The counter witnessed a trading volume of 2.24 million shares versus an average volume of 1.82 million shares during last trading session. This continues to be an interesting story, and we look forward to updating it again soon on Nabriva Therapeutics plc.

Like this


22 September 2017
IT officer's son murdered by kidnappers, body recovered in Bengaluru
According to the police, the abductors made a decision to kill him, after they realised that the family had gone to the cops. 6 men have been arrested in connection with the crime, though details of the charges against them are not yet known.

22 September 2017
Cooper to veto GenX money, repeal of plastic bag ban
GenX is a relatively new, unregulated chemical with little scientific data about its health effects. Cooper, in a statement, said "there is no room for political posturing or hollow solutions".

22 September 2017
Man flees into woods while being shot at in Nova Scotia
RCMP say the man has been released from custody and is scheduled to appear in Annapolis Royal Provincial Court on November 27. Annapolis District RCMP say they received a complaint on September 13 of an abandoned pickup truck on Guinea Road.

22 September 2017
Chelsea boss Conte: Six teams can win Premier League title
And asked about his title rivals, Conte said : 'You know very well that, in England, there are six top teams. Michy Batshuayi netted a hat-trick, while Kenedy and Charly Musonda also scored.

22 September 2017
Kellogg (K) Given Daily News Impact Score of 0.12
Kellogg Company, launched on December 11, 1922, is a manufacturer and marketer of ready-to-eat cereal and convenience foods. The company reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.92 by $0.05.

22 September 2017
China supports peaceful resolution to North Korea issue: Foreign Ministry
"We call upon all parties to play a constructive role in easing tensions". "Negotiation is the only way out, and deserves every effort".

22 September 2017
Moon Calls for Peaceful Resolution to North Korean Nuclear Issue
Trump said Thursday the USA will impose additional sanctions over the communist country's nuclear weapons buildup. Trump signaled ahead of the meeting that new sanctions would be announced against North Korea.

22 September 2017
Here's How Markets Are Reacting to the Fed Policy Meeting
As expected, central bank officials voted to hold the benchmark federal funds rate steady at between 1 percent and 1.25 percent. So, it is quite rational on the part of the Fed to signal one more rate hike this year and three rate hikes next year.

22 September 2017
Donaldson Company Inc (DCI) Needle Moving 0.42%
Following the completion of the sale, the director now owns 495,572 shares of the company's stock, valued at $33,892,169.08. Healy now forecasts that the company will earn $0.96 per share for the quarter, up from their previous forecast of $0.91.

22 September 2017
Threat prompts lockdown of Windermere High School
After the investigation concluded, officers concluded there was not a threat and the lockdown was lifted. Portland police said no arrest has been made and the incident is being investigated.